Off-Label Use of Intravenous Immunoglobulin for Dermatological Conditions: Clinical Effectiveness


( Last Updated : November 3, 2017)
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1153-000

Details


Question


  1. What is the clinical effectiveness of the off-label use of intravenous or subcutaneous immunoglobulin for the treatment of dermatological conditions?


Key Message

Twenty-one systematic reviews and meta-analyses and five randomized controlled trials were identified regarding the clinical effectiveness of the off-label use of intravenous or subcutaneous immunoglobulin for the treatment of dermatological conditions.